Tenidap is an anti-inflammatory drug whose mechanism of action is not
fully understood. It has been shown to block plasma membrane anion tra
nsport and to decrease release of interleukin-1 beta, probably via the
inhibition of interleukin-1 beta converting enzyme. In the present st
udy we showed that: (a) tenidap increases the sensitivity of mouse mac
rophages to cytotoxic effects mediated by extracellular ATP; (b) tenid
ap increases lucifer yellow uptake through the macrophage ATP receptor
; (c) pretreatment with oxidised ATP, a blocker of the P2Z/P2X(7) rece
ptor, inhibits cytotoxicity and lucifer yellow uptake due to the combi
ned effects of ATP and tenidap; (d) macrophages lacking the P2Z/P2X(7)
receptor are resistant to the synergistic effect of tenidap and ATP.
The results suggest that tenidap synergises with extracellular ATP for
activation of the P2Z/P2X(7) receptor. (C) 1998 Elsevier Science B.V.
All rights reserved.